Your browser doesn't support javascript.
loading
Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity.
Lin, Yuan-Na; Schmidt, Marcel O; Sharif, Ghada M; Vietsch, Eveline E; Kiliti, Amber J; Barefoot, Megan E; Riegel, Anna T; Wellstein, Anton.
Afiliação
  • Lin YN; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Schmidt MO; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Sharif GM; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Vietsch EE; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Kiliti AJ; Department of Surgery, Erasmus Mc, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Barefoot ME; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Riegel AT; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  • Wellstein A; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Oncoimmunology ; 11(1): 2027136, 2022.
Article em En | MEDLINE | ID: mdl-35127250
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Compostos Heterocíclicos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Compostos Heterocíclicos Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article